Ketone drink tested for appetite effects in obesity
NCT ID NCT06327464
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a ketone supplement drink can change appetite-related hormones in adults with and without obesity. Twenty-six people took part, each receiving the ketone drink on one visit and a placebo on another. Researchers measured hunger and fullness hormones before and after a meal to see if the supplement made a difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
26 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 19-45 years * Body mass index (BMI): 18.5 - 40.0 kg/m2 * For females: Premenopausal, with regular menstrual cycle (every 21-38 days, by self-report) OR lack of regular menstrual cycles due to oral contraceptive or intrauterine device (IUD) use * Sedentary or recreationally active, defined as: \<300 minutes per week of voluntary exercise at moderate intensity or greater over the past 12 weeks * Not currently pregnant or lactating, not planning to become pregnant in the next 12 weeks * Ability and willingness to fast for 12 hours before each study day visit * If applicable: * For people who occasionally (i.e., \<1x/day) use cannabis (including cannabidiol-based products): ability and willingness to abstain from cannabis for two days prior to each study day visit, the day of each study visit, and during each ad libitum diet phase. * For people who use cannabis daily: ability and willingness to continue to use the exact same amount of cannabis as they normally use for two days prior to each study day visit, the day of each study visit, and during each ad libitum diet phase. Exclusion Criteria: * Current or previous major comorbidities, by self-report, including: * Cardiovascular diseases * Diabetes (type 1 or type 2) * Cancer * Thyroid diseases * Human immunodeficiency virus or hepatitis B or C * Renal diseases * Hepatic diseases * Polycystic ovary syndrome * Uncontrolled/untreated (self-report): * Hypertension * Dyslipidemia * Uncontrolled Ssleep disorders (e.g., insomnia) * Any other condition that may affect appetite and energy balance * Currently or in the past six months: * Use of regular medication or supplement that may affect appetite, energy balance, or sleep * Regular use of tobacco or nicotine products * Starting any new prescription medication within two weeks of the first study day visit or during the study * Working night shifts or traveling across more than 2 time zones within two weeks of and throughout the study * Food intolerances or allergies that cannot be accommodated * History of surgical procedure for weight loss at any time (e.g., gastroplasty, gastric bypass, gastrectomy or partial gastrectomy, adjustable banding, gastric sleeve); history of extensive bowel resection for other reasons * Current alcohol or substance abuse (score \>2 on the cut down-annoyed-guilty-eye opener \[CAGE\] questionnaire16) * Current or past history of eating disorders including anorexia nervosa, bulimia, binge eating disorder (self-report or score \>20 on the Eating Attitudes Test - 26 \[EATS-26\] questionnaire17) * Weight loss \>5% in past 12 weeks for any reason
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Appetite are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of British Columbia - Okanagan
Kelowna, British Columbia, V1V1V7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?